Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Training the Innate Immune System Against SARS-COV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study

NCT04523246 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT04523246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04523246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Training the Innate Immune System Against SARS-COV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents: A Randomized, Doubled-Blinded, Comparative Group Observational Study
Lead sponsor
University of Oklahoma
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2020
Completion date
May 19, 2023
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy and immunology, corona virus infection, herpes zoster